SEC 13F Intelligence

Saturna Capital Corp / LLY

Saturna Capital Corp’s Eli Lilly & Co Position

Does Saturna Capital Corp own Eli Lilly & Co (LLY)? Yes555.1K shares worth $511M (+7.16% of its 13F portfolio) as of Q1 2026, down from 561.3K shares the prior filed quarter.

Position Value
$511M
Q1 2026
Shares
555.1K
% of Portfolio
+7.16%
Quarters Held
29
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $114MQ4 ’18Q1 ’19: $127MQ2 ’19: $109MQ3 ’19: $110MQ4 ’19: $129MQ4 ’19Q1 ’20: $128MQ2 ’20: $151MQ4 ’20: $136MQ1 ’21: $172MQ1 ’21Q2 ’21: $211MQ3 ’21: $215MQ4 ’21: $245MQ1 ’22: $264MQ1 ’22Q2 ’22: $264MQ3 ’22: $264MQ4 ’22: $298MQ1 ’23: $274MQ1 ’23Q2 ’23: $373MQ3 ’23: $408MQ4 ’23: $415MQ1 ’24: $539MQ1 ’24Q2 ’24: $618MQ3 ’24: $575MQ4 ’24: $486MQ1 ’25: $496MQ1 ’25Q2 ’25: $463MQ3 ’25: $450MQ4 ’25: $603MQ1 ’26: $511MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026555.1K$511M+7.16%
Q4 2025561.3K$603M+8.00%
Q3 2025589.5K$450M+5.80%
Q2 2025593.6K$463M+6.25%
Q1 2025600.8K$496M+7.43%
Q4 2024629.1K$486M+6.59%
Q3 2024649.4K$575M+7.52%
Q2 2024682.9K$618M+8.21%
Q1 2024692.6K$539M+7.44%
Q4 2023711.3K$415M+6.46%
Q3 2023760.2K$408M+7.22%
Q2 2023795.7K$373M+6.45%
Q1 2023796.8K$274M+5.30%
Q4 2022814.9K$298M+6.41%
Q3 2022815.6K$264M+6.43%
Q2 2022815.6K$264M+6.26%
Q1 2022920.4K$264M+5.31%
Q4 2021920.3K$245M+4.39%
Q3 2021920.3K$215M+4.33%
Q2 2021919.8K$211M+4.33%
Q1 2021919.8K$172M+3.83%
Q4 2020921.1K$136M+3.47%
Q2 2020921.1K$151M+4.24%
Q1 2020921.1K$128M+4.14%
Q4 2019981.1K$129M+3.49%
Q3 2019981.1K$110M+3.19%
Q2 2019981.3K$109M+3.19%
Q1 2019980.5K$127M+3.71%
Q4 2018985.0K$114M+3.84%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saturna Capital Corp’s full portfolio or all institutional holders of LLY.